Cargando…

Amino acids – Guidelines on Parenteral Nutrition, Chapter 4

Protein catabolism should be reduced and protein synthesis promoted with parenteral nutrion (PN). Amino acid (AA) solutions should always be infused with PN. Standard AA solutions are generally used, whereas specially adapted AA solutions may be required in certain conditions such as severe disorder...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, J., Boehles, H. J., Blumenstein, I., Goeters, C., Schulz, R.
Formato: Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795371/
https://www.ncbi.nlm.nih.gov/pubmed/20049071
http://dx.doi.org/10.3205/000083
_version_ 1782175427041689600
author Stein, J.
Boehles, H. J.
Blumenstein, I.
Goeters, C.
Schulz, R.
author_facet Stein, J.
Boehles, H. J.
Blumenstein, I.
Goeters, C.
Schulz, R.
author_sort Stein, J.
collection PubMed
description Protein catabolism should be reduced and protein synthesis promoted with parenteral nutrion (PN). Amino acid (AA) solutions should always be infused with PN. Standard AA solutions are generally used, whereas specially adapted AA solutions may be required in certain conditions such as severe disorders of AA utilisation or in inborn errors of AA metabolism. An AA intake of 0.8 g/kg/day is generally recommended for adult patients with a normal metabolism, which may be increased to 1.2–1.5 g/kg/day, or to 2.0 or 2.5 g/kg/day in exceptional cases. Sufficient non-nitrogen energy sources should be added in order to assure adequate utilisation of AA. A nitrogen calorie ratio of 1:130 to 1:170 (g N/kcal) or 1:21 to 1:27 (g AA/kcal) is recommended under normal metabolic conditions. In critically ill patients glutamine should be administered parenterally if indicated in the form of peptides, for example 0.3–0.4 g glutamine dipeptide/kg body weight/day (=0.2–0.26 g glutamine/kg body weight/day). No recommendation can be made for glutamine supplementation in PN for patients with acute pancreatitis or after bone marrow transplantation (BMT), and in newborns. The application of arginine is currently not warranted as a supplement in PN in adults. N-acetyl AA are only of limited use as alternative AA sources. There is currently no indication for use of AA solutions with an increased content of glycine, branched-chain AAs (BCAA) and ornithine-α-ketoglutarate (OKG) in all patients receiving PN. AA solutions with an increased proportion of BCAA are recommended in the treatment of hepatic encephalopathy (III–IV).
format Text
id pubmed-2795371
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher German Medical Science GMS Publishing House
record_format MEDLINE/PubMed
spelling pubmed-27953712010-01-04 Amino acids – Guidelines on Parenteral Nutrition, Chapter 4 Stein, J. Boehles, H. J. Blumenstein, I. Goeters, C. Schulz, R. Ger Med Sci Article Protein catabolism should be reduced and protein synthesis promoted with parenteral nutrion (PN). Amino acid (AA) solutions should always be infused with PN. Standard AA solutions are generally used, whereas specially adapted AA solutions may be required in certain conditions such as severe disorders of AA utilisation or in inborn errors of AA metabolism. An AA intake of 0.8 g/kg/day is generally recommended for adult patients with a normal metabolism, which may be increased to 1.2–1.5 g/kg/day, or to 2.0 or 2.5 g/kg/day in exceptional cases. Sufficient non-nitrogen energy sources should be added in order to assure adequate utilisation of AA. A nitrogen calorie ratio of 1:130 to 1:170 (g N/kcal) or 1:21 to 1:27 (g AA/kcal) is recommended under normal metabolic conditions. In critically ill patients glutamine should be administered parenterally if indicated in the form of peptides, for example 0.3–0.4 g glutamine dipeptide/kg body weight/day (=0.2–0.26 g glutamine/kg body weight/day). No recommendation can be made for glutamine supplementation in PN for patients with acute pancreatitis or after bone marrow transplantation (BMT), and in newborns. The application of arginine is currently not warranted as a supplement in PN in adults. N-acetyl AA are only of limited use as alternative AA sources. There is currently no indication for use of AA solutions with an increased content of glycine, branched-chain AAs (BCAA) and ornithine-α-ketoglutarate (OKG) in all patients receiving PN. AA solutions with an increased proportion of BCAA are recommended in the treatment of hepatic encephalopathy (III–IV). German Medical Science GMS Publishing House 2009-11-18 /pmc/articles/PMC2795371/ /pubmed/20049071 http://dx.doi.org/10.3205/000083 Text en Copyright © 2009 Stein et al. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free to copy, distribute and transmit the work, provided the original author and source are credited.
spellingShingle Article
Stein, J.
Boehles, H. J.
Blumenstein, I.
Goeters, C.
Schulz, R.
Amino acids – Guidelines on Parenteral Nutrition, Chapter 4
title Amino acids – Guidelines on Parenteral Nutrition, Chapter 4
title_full Amino acids – Guidelines on Parenteral Nutrition, Chapter 4
title_fullStr Amino acids – Guidelines on Parenteral Nutrition, Chapter 4
title_full_unstemmed Amino acids – Guidelines on Parenteral Nutrition, Chapter 4
title_short Amino acids – Guidelines on Parenteral Nutrition, Chapter 4
title_sort amino acids – guidelines on parenteral nutrition, chapter 4
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795371/
https://www.ncbi.nlm.nih.gov/pubmed/20049071
http://dx.doi.org/10.3205/000083
work_keys_str_mv AT steinj aminoacidsguidelinesonparenteralnutritionchapter4
AT boehleshj aminoacidsguidelinesonparenteralnutritionchapter4
AT blumensteini aminoacidsguidelinesonparenteralnutritionchapter4
AT goetersc aminoacidsguidelinesonparenteralnutritionchapter4
AT schulzr aminoacidsguidelinesonparenteralnutritionchapter4
AT aminoacidsguidelinesonparenteralnutritionchapter4